Data
Click on Protocol Number of interest to view study-related documentation or download data files.
(DTMC data files are under development.)
| Division | Study Number | Title | Investigator(s) | Release Date |
|---|---|---|---|---|
| CTN | NIDA-CTN-0079 | Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT) | John Rotrosen, M.D., Kathryn Hawk, M.D., M.H.S., Ryan McCormack, M.D. | Nov 04, 2024 |
| CTN | NIDA-CTN-0081 | Capturing Opioid Use Disorder Electronically & Patient Reported Outcomes (CODE-PRO) | Arjun Krishna Venkatesh, MD, MBA, MHS, Kathryn Hawk, M.D., M.H.S., Richard Andrew Taylor, MD, MHS | Dec 06, 2024 |
| CTN | NIDA-CTN-0083 | Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services (Social Media PrEP) | Jeffrey D. Klausner, M.D. | Apr 09, 2025 |
| CTN | NIDA-CTN-0093 | Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool | Gerald Cochran, PhD, T. John Winhusen, Ph.D. | Apr 13, 2023 |
| CTN | NIDA-CTN-0095A1 | Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder | Gavin Bart, Ph.D., M.D., Rebecca Rossom, M.D., M.S. | Apr 22, 2025 |
| CTN | NIDA-CTN-0095A2 | Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians | Stephanie Hooker, Ph.D., M.P.H., Rebecca Rossom, M.D., M.S., A. Lauren Crain, Ph.D., Gavin Bart, Ph.D., M.D. | May 24, 2024 |
| CTN | NIDA-CTN-0097 | Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (SWIFT) | Adam Bisaga, M.D., Edward V. Nunes, M.D. | Feb 11, 2025 |
| CTN | NIDA-CTN-0105 | Integrating Pharmacy-Based Prevention and Treatment of Opioid and Other Substance Use Disorders: A Survey of Pharmacists and Stakeholders | Li-Tzy Wu, Psy.D. | May 23, 2025 |
| CTN | NIDA-CTN-0134 | Identifying Regional “Hotspots” and Potential Correlates of Precipitated Withdrawal During Buprenorphine Induction in Fentanyl Users Through Prescriber Survey Responses and Patient Urine Drug Test Results (Buprenorphine-Precipitated Withdrawal Hotspots and Correlates) | LaTrice Montgomery, Ph.D., T. John Winhusen, Ph.D. | Jun 03, 2025 |
| DTMC | NIDA-CTO-0001 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence | Eugene Somoza, M.D. | Dec 04, 2014 |